S-1 · resale registration
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Wholesale-Durable Goods, NECIndustry: Medical - PharmaceuticalsCountry: MYExchange: Nasdaq
DilutionScan read 37 of Bio Green Med Solution, Inc.'s SEC filings and found 11 warrant series, 6 convertibles, 1 ATM program, 2 equity lines, 3 shelf registrations, 4 S-1 registrations and 3 completed offerings on file for BGMS. The latest dilution event on file is a registration statement on Oct 23, 2026. Analysis updated Oct 29, 2026.
BGMS
Going-concern warning and reverse merger
BGMS is a tiny micro-cap with a $4.6M market cap that is currently burning cash and facing serious operational questions. The company reported $747K in revenue for FY 2025, up from $43K the prior year, but still lost $3.0M in net income. It holds $3.5M in cash against negligible debt, which provides a runway of roughly 38 months at current burn rates.
Raise routes on file: shelf awaiting effectiveness + effective S-1 · latest dilution event 11 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Oct 23, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Proposed maximum
Shares registered
Issued 2024
Proposed maximum
Shares registered
Issued 2025
Proposed maximum
Shares registered
Issued 2025
Proposed maximum
Shares registered
Issued 2024
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2021
Total capacity
Sold to date
Issued 2025
Commitment
Sold to date
Issued 2025
Commitment
Sold to date
Issued 2023
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Medical - Pharmaceuticals, then the closest in size. All tickers A to Z